Dallas、TXにおけるうつ病の臨床試験
Dallasとその周辺地域（約30マイル以内）の拠点で、うつ病に関する12件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
被験者募集中第2相
- FutureSearch Trials of Dallas, Dallas
Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression
被験者募集中観察研究
- Child and adolescent psychiatrist at the Children's Health Psychiatry Clinic., Dallas
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
被験者募集中第2相
- Seaport Investigator Site, Dallas
Accelerated rTMS for Substance Use Disorder and Depression
被験者募集中
- UT Southwestern Medical Center, Dallas
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
被験者募集中第3相
- Relaro Medical Trials /ID# 227156, Dallas
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Dallas
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
被験者募集中健康なボランティア歓迎
- Parkland Health & Hospital System, Dallas
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
被験者募集中
- University of Texas Southwestern, Dallas
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
被験者募集中
- UT Southwestern Parkland Health and Hospital System, Dallas
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
被験者募集中
- University of Texas Southwestern Medical Center, Dallas
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Dallas
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
被験者募集中第4相
- Clinical Research Site, Dallas
- Clinical Research Site, Dallas
他の都市におけるうつ病の試験
- Boston, MA52件の研究
- New York City, NY45件の研究
- Philadelphia, PA26件の研究
- Atlanta, GA24件の研究
- Chicago, IL24件の研究
- Pittsburgh, PA22件の研究
- San Diego, CA21件の研究
- Charleston, SC19件の研究
- Houston, TX18件の研究
- Orlando, FL17件の研究
- Los Angeles, CA17件の研究
- Miami, FL16件の研究
Dallasにおける他の研究
- 乳がん55件の研究
- 非小細胞肺癌52件の研究
- 転移性癌42件の研究
- 心不全42件の研究
- がん（全種類）37件の研究
- 前立腺がん36件の研究
- 大腸癌33件の研究
- 肥満症30件の研究
- 卵巣がん28件の研究
- 膀胱癌27件の研究
- 肺がん27件の研究
- 子宮内膜がん24件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。